Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: A nationwide survey in the Netherlands

Nephrology Dialysis Transplantation

Volumn 23, Issue 11, 2008, Pages 3534-3538

  Hofstra, Julia M ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cyclophosphamide; ESRD; Immunosuppression; Membranous nephropathy

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA BASE; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FAILURE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; NETHERLANDS; PRIORITY JOURNAL; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; TREATMENT RESPONSE;

ADULT; AGED; CREATININE; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GLUCOCORTICOIDS; HEALTH SURVEYS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NETHERLANDS; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 54149099598     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn350     Document Type: Article

References (10)

1. du Buf-Vereijken PW, Branten AJW, Wetzels JFM. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis 2005; 46: 1012-1029
2. Ponticelli C, Zucchelli P, Passerini P et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 45: 1600-1604
3. du Buf-Vereijken PW, Branten AJW, Wetzels JFM. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival bur high relapse rate. Nephrol Dial Transplant 2004; 19: 1142-1148
4. Torres A, Dominguez-Gil B, Carreno A et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kidney Int 2002; 61: 219-227
5. Perna A, Schiepatti A, Zamora J et al. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis 2004; 44: 385-401
6. du Buf-Vereijken PW, Feith GW, Hollander DA et al. Restrictive use of immunosuppressive treatment in patients with idiopathic membranous nephropathy: high renal survival in a large patient cohort. Q J Med 2004; 97: 353-360
7. Branten AJW, Reichert LJM, Koene RAP et al. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency. Q J Med 1998; 91: 559-566
8. Jha V, Ganguli A, Saha TK et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 2007; 18: 1899-1904
9. Cattran DC, Delmore T, Roscoe J et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. New Engl J Med 1989; 320: 210-215
10. Cameron JS, Healy MJR, Adu D. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. Q J Med 1990; 74: 133-156